Beta Drugs News

Beta Drugs Achieves Key Regulatory Milestones

Beta Drugs Limited secures GMP inspection approval in Azerbaijan and receives first generic product registrations in Philippines, expanding CIS and Southeast Asian market access.

Beta Drugs Gets Philippines Product Registration

Beta Drugs Limited secures product registration for two generic brands in the Philippines, with additional approvals anticipated in the near future.

Beta Drugs Acquires 66% Stake in Nivian Lifesciences

Beta Drugs announces ₹69.4 crore acquisition of 66.09% stake in IVF specialist Nivian Lifesciences, marking entry into women's health segment. Stock jumps 4% on announcement.

Beta Drugs to Acquire 66.09% Stake in Nivian Life

Beta Drugs announces acquisition of majority 66.09% stake in Nivian Life Sciences for ₹694 million, marking significant expansion in pharmaceutical sector through strategic investment.

Beta Drugs Receives Approval to Migrate from SME Platform to Main Board Listing

Beta Drugs has received approval to list its equity shares on the main board after migrating from the SME Emerge platform. This migration represents a significant milestone for the company, allowing it to access broader investor base and enhanced market visibility.